Annex 1 Manufacture of Sterile Medicinal Products

Knowing and applying the GMP regulations is one of the key elements in the manufacture of medicinal products, particularly in the manufacture of sterile medicinal products. Major changes have recently been made to the EU GMP guideline covering manufacture of sterile medicinal products (Annex 1).

This webinar is designed for staff who are new to working in sterile manufacturing or who wish to learn about the recent Annex 1 revisions. It will discuss what controls and documentation must be in place to ensure product quality and patient safety for both aseptically prepared and terminally sterilized products.

Areas Covered in the Session :

  • GMP regulation of sterile products
  • Why are sterile products different?
  • Background to the Annex 1 guideline
  • Importance of product, equipment and people flow
  • Room classifications and particulate monitoring
  • Sterilization methods for materials and equipment
  • Contamination by operators: the importance of gowning
  • Water systems
  • Media fills
Who Should Attend:

  • Staff involved with manufacture of sterile medicinal products to be marketed in EU
  • Quality Assurance Departments
  • Manufacturing Departments
  • Regulatory Affairs Departments
  • Research and Development Departments
  • GMP/GDP Compliance Departments
  • Contract Manufacturing Organizations


Robert Haslam

Robert Haslam, Managing Director, Somerset House Consultants has over forty years of experience in Quality Assurance, Production, Development, Clinical Trials and Regulatory Affairs gained in multinational and start-up companies. He is the Managing Director of a consultancy providing quality assurance, manufacturing, development and training support to pharmaceutical companies worldwide. He is an EU ‘Qualified Person’ for marketed and investigational products, including steriles and non-steriles, generics, biopharmaceuticals, herbals. He is also an ISO-qualified Lead Auditor; experienced in EU & FDA Good Manufacturing Practice.

He has extensive experience in GMP audits of drug substance, drug product and Investigational Medicinal Product manufacturers; outsourced activities; supply chain risk management. He has a successful track record of strategic management, facility qualification, designing and implementing quality systems, managing quality remediation programs, product development and outsourcing. He has designed and delivered bespoke GMP training courses to companies worldwide. Expert witness in litigation involving GMP compliance.

  Go PRIME   🛈 $ 240 SELECT
  Personal Plan 🛈 $ 3000 SELECT
  Business Plan 🛈 $ 9000 SELECT

  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance